NDC Registered Products In Stock

Retatrutide

A novel, single peptide agonist targeting three incretin receptors: the glucose-dependent insulinotropic polypeptide (GIP), and receptors.

Tags: Triple incretin receptor agonist GLP-1/GIP/ peptide agonist Novel multi-receptor peptide

Sample Policy

Free Sample / Freight Charged / to final agreement

Expert Support

Pharmaceutical Team

Key Specifications

CAS

2381089-83-2

Purity

99.0%

MF

C221H342N46O68

MW

4731.33

Medical Use Specifications Content

Medical Use

Investigational Drug: Currently in clinical trials for the treatment of obesity and type 2 diabetes. It represents a next-generation "triple-hormone" therapy aimed at achieving superior weight loss and metabolic benefits.

Technical Specifications

Parameter Specification
CAS Number 1261289-04-6
MF C221H342N46O68
MW 4731.33
Purity 99%
Sequence H-Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
storage temp. Store at 2-8 degrees Celsius in a dry and cool place.
Appearance White powder

Content

Related Peptides

Ready to Advance Your Research?

Contact our pharmaceutical team for custom peptide synthesis, bulk orders, and technical support for your drug development needs.

Get Synthesis Quote